Bridging Innovations, Entrepreneurs, and Opportunities to Advance Global Biopharmaceuticals Development
Saturday, June 9, 2018
Wayne T. Hockmeyer Auditorium
MedImmune, A Member of the AstraZeneca Group
One MedImmune way, Gaithersburg, MD 20878
Job Opportunities from our partners and sponsors
Morning Session Focusing on Immune-Oncology
7:30-8:30 Registration and Continental Breakfast; Exhibition Booth Setup
8:30-8:35 Welcome to CBA 23rd Annual Conference
Dong Shen, M.D., Ph.D., President of CBA
8:35-8:50 Opening Remarks
1. Mr. Luis Borunda, Deputy Secretary of the State of Maryland
2. Mrs. Xueyuan Xu, Minister, Embassy of the People’s Republic of China in the United States of America
3. AZ/MEDI-TBD
8:50-8:55 Introduction of CBA Brilliant Achievement Awardee: Lieping Chen, M.D., Ph.D.
Frank Li Li, M.D., Ph.D., President-Elect of CBA
8:55-9:20 CBA Brilliant Achievement Award Presentation
Immunological Principles of Anti-PD-1/PD-L1 Cancer Therapy
Lieping Chen, M.D., Ph.D., Professor, School of Medicine, Yale University
9:20-9:25 Introduction of CBA Brilliant Achievement Awardee: Richard Pazdur, M.D.
Dong Shen, M.D., Ph.D., President of CBA
9:25-9:50 CBA Brilliant Achievement Award Presentation
1971-2018: Personal Reflections on Nixon’s War on Cancer
Richard Pazdur, M.D., Director, Oncology Center of Excellence, FDA, USA
9:50-10:00 Coffee Break
10:00-10:05 Introduction of CBA Brilliant Achievement Awardee: Yong-Jun Liu, M.D., Ph.D.
Xu-Rong Jiang, M.D., Ph.D., Immediate Past President of CBA
10:05-10:30 CBA Brilliant Achievement Award Presentation
Follow the Science and Capture the Opportunity
Yong-Jun Liu, M.D., Ph.D., Head of Research, Global R&D, Sanofi
10:30-10:35 Introduction of CBA Brilliant Achievement Awardee: Laurence J.N. Cooper, M.D., Ph.D.
Sujuan Ba, Ph.D., Former President of CBA, President and COO of the National Foundation for Cancer Research (NFCR)
10:35-11:00 CBA Brilliant Achievement Award Presentation
The Genetic Engineering of T Cells: From Bench, to Bedside, to Boardroom
Laurence JN Cooper, M.D., Ph.D., CEO, ZIOPHARM Oncology
11:00-11:15 Panel Discussion
Moderator: Sujuan Ba, Ph.D.
11:15-11:35 Special Presentation by WuXi AppTec: Creating a Pharmaceutical Innovation Ecosystem
Xin Zhang, Ph.D., Vice President & Global Head of DMPK, Bioanalysis & Abgent, WuXi AppTec
11:35-12:35 Global Drug Development: ICH and Role of China
Co-Chairs: Jingyu (Julia) Luan, Ph.D., CDER, FDA, USA; Xinyu Weng, Ph.D., CNDA, China
11:35-12:00 Issues in Multiregional Clinical Trials
Aloka Chakravarty, Ph.D., Acting Director, Office of Biostatistics, CDER, FDA, USA
12:00-12:25 CNDA’s Regulatory Reform: Opportunities and Challenges
Gang Wang, Ph.D., Former Chief Scientist, CDE, CNDA, China
12:25-12:35 Panel Discussion
Dan Zhang, M.D., MPH, Chairman, Fountain Medical Development
Bill Wang, Ph.D., Executive Director, Clinical Safety Statistics, Merck & Co
Shoubai Chao, Ph.D., Chief Operating Officer, CanSino Biologics
12:35-1:30 Lunch
Afternoon Session
1:30-2:30 Parallel Sections-A
1:30-2:30 (A1) Entrepreneur Incubators and Collaboration （Auditorium）
Chair: Huihua (Helen) Mao, Ph.D., MBA, Co-founder and Senior Vice President, CanSino Biologics
1:30-1:45 Incubators in Montgomery County, Maryland
a. Biotech and Montgomery County’s Economy
Lily Qi, Assistant Chief Administrative Officer, Montgomery County Office of the County Executive
b. Supporting Entrepreneurs in a Sustainable Local Economy
Sarah Miller, Vice President and Chief of Staff, Montgomery County Economic Development Corporation
1:45-2:05 Incubators in China
a. Incubating Future Innovators and Entrepreneurs in Life Science
Zhe Zhi, Vice General Manager, China Resources Life Science Park Company
b. Video: Introduction to Tianjin Economic-Technological Development Area (TEDA)
2:05-2:15 Maryland Resources for Business Growth
Felicia Pullam, Regional Manager, East Asia & Investment Team Lead, Office of International Investment and
Trade, Maryland Department of Commerce
2:15-2:25 Introduction of Maryland International Incubator
Alex Wang, Ph.D., Director, Maryland International Incubator, University of Maryland (College Park), MD, USA
2:25-2:30 Panel Discussion
1:30-2:30 (A2) Advanced Translational Medicine-SCBA (Multipurpose Room)
Co-Chairs: Mitchell Ho, Ph.D.; Wanjun Chen, Ph.D.
1:30-1:50 CAR-T Cells Targeting Glypicans in Cancer
Mitchell Ho, Ph.D., Senior Investigator, Laboratory of Molecular Biology, NCI, NIH
1:50-2:10 Gut Microbiome Controls Liver Tumor Growth via Bile Acid-regulated NKT Cells.
Chi Ma, Ph.D., Staff Scientist, Thoracic and Gastrointestinal Oncology, NCI, NIH
2:10-2:30 T Regulatory Cells for Immunotherapy to Autoimmunity and Cancer
Wanjun Chen, Ph.D., Senior Investigator, Chief, Mucosal Immunology Section, NIDCR, NIH
2:30-3:30 Parallel Sections-B
2:30-3:30 (B1) Artificial Intelligence and Big Data in Biopharmaceutical Development (Auditorium)
Chair: Chuanhua (Julia) Xing, Ph.D., Vice President of CBA, Founder, XPrecision and ShiHua Big Data Healthcare
2:30-2:50 Application of Deep Learning in Drug Discovery
Qingsong Zhu, Ph.D., Chief Operating Officer, InSilico Medicine!
2:50-3:10 Burn the Haystack: Finding the Needle in Clinical Notes and Genomics at Scale
Nathan Salmon, Chief Architect, MetiStream
3:10-3:30 Deep Learning Convolutional Neural Networks Techniques and Their Applications in Biomedical Sciences – A
Successful Example in Lung Imaging
ShihChung Benedict Lo, Ph.D., Georgetown University Medical Center & Virginia Tech.
2:30-3:30 (B2) Real World Evidence Medicine in Biopharmaceutical Development (Multipurpose Room)
Chair: Yifan Zhai, M.D., Ph.D., Chief Medical Officer, Ascentage Pharma
2:30-2:50 Information Exchange and Data Transformation (INFORMED)
Sean Khozin, M.D., MPH, Associate Director (Acting), Oncology Center of Excellence, FDA, USA
2:50-3:10 Realizing the Potential of Real World Data and Evidence
Iksha Herr, MS, PMP, Real World Evidence Data & Analytics Leader, AstraZeneca
3:10-3:30 Panel Discussion
Panelist
Xia Wang, Ph.D., Director, Health Informatics, AstraZeneca
3:30-3:40 Cafe Break
3:40-5:00 Entrepreneurs and Investors
Co-Chairs: Dazhi Lai, Ph.D., Vice President, CBA; Da Liu, Pharm.D, Managing Director of CR-CP Life Science Fund
3:40-3:50 Proprietary Technologies to Produce the Next Generation Growth Factors in Green Algae
Jun Wang, Ph.D., Founder and CEO, Phycin, Frederick, Maryland, USA
3:50-4:00 Immunotherapy for Solid Tumors by Chimeric Antigen Receptor (CAR)-Modified Allogeneic Natural Killer (NK) Cells
Qihong Sun, M.D., Ph.D., Chief Medical Officer, Asclepius Technology Company Group (ATCG), Suzhou, China
4:00-4:10 Revamping Electroporation for Fast Manufacturing of CAR-T Cells
Jian Chen, Ph.D., Founder and CEO, Celetrix
4:10-4:20 Stimulation of Gamma Delta T Cells for the Treatment of Epithelial Solid Tumors
Jeff Galvin, Founder and CEO, American Gene Technology, Gaithersburg, Maryland, USA
4:20-4:30 Targeted and Personalized Peptide Therapy – 188 Re P2045 to Treat Lung Cancer
Christopher Adams, CEO, Andarix Pharmaceuticals, Boston, MA, USA
4:30-4:40 Building a China Biopharma with Distinguished Team, Pipeline and Portfolios
Joan (Huaqiong) Shen, M.D., Ph.D., Head of R&D, I-Mab Biopharma
4:40-5:00 Panel Discussion
All presenters
Xiaochang Dai, Ph.D., Rotating Boulder Fund
Yi Dang, Ph.D., Consultant and Investor, President of BWIA
Da Liu, Pharm.D.
5:00-6:30 CEO Roundtable
Co-chairs: Xurong Jiang, M.D., Ph.D., Immediate Past President of CBA,
Dajun Yang, M.D., Ph.D., Former President of CBA, Co-Founder, Chairman & CEO of Ascentage Pharma
Christopher Adams, CEO of Andarix Pharmaceuticals
Hua Bai, Chairman, Hisun Pharmaceutical
Jeff Galvin, Founder and CEO of American Gene Technologies
Patrick Lu, Ph.D., Founder, President and CEO of Sirnaomics
Yingxian Xiao, Ph.D., CEO of Shanghai Furen Medicine R&D Co.
Dong Xie, Ph.D., Founder and Chairman of Frontier Biotech
Dajun Yang, M.D., Ph.D., Co-Founder, Chairman & CEO of Ascentage Pharma
Bing Yao, Ph.D., CEO of Viela Bio
Dan Zhang M.D., MPH, Chairman of Fountain Medical Development
Xin Zhang, Ph.D., Vice President & Global Head of DMPK, Bioanalysis & Abgent, WuXi AppTec
6:30-7:15 Reception Cafeteria
7:15-8:45 Dinner Banquet Cafeteria
9:00 Conference/Event Concludes